SCHEMBL5045640

SCHEMBL5045640

CO[C@](Cc1ccccc1)(C(=O)NCc1ccc(C#N)cc1)C1=COCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
EPHX2 P34913 1/20 0.38
MAOA P21397 1/20 0.38
MMP8 P22894 4/20 0.38
PPARA Q07869 1/20 0.37
RIPK1 Q13546 1/20 0.36
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
ABCB1 P08183 1/20 0.35
HPGD P15428 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346144 0.78 SMN1; SMN2 (0.37) MMP8PPARAKMT2ARAB9A
SCHEMBL5882355 0.72 RORC (0.35) SIGMAR1MEN1KMT2ATMEM97ABCB1
SCHEMBL5042707 0.71 EPHX2 (0.54) SLC1A3SLC1A2EPHX2MAOAMMP8
SCHEMBL5042714 0.71 EPHX2 (0.54) SLC1A3SLC1A2EPHX2MAOAMMP8
SCHEMBL6885612 0.68 PKM (0.43) SLC1A3SLC1A2EPHX2PPARAHTR1A
SCHEMBL5038038 0.68 EPHX2 (0.47) SLC1A3SLC1A2EPHX2MAOAPPARA
SCHEMBL5038036 0.68 EPHX2 (0.47) SLC1A3SLC1A2EPHX2MAOAPPARA
SCHEMBL1131124 0.67 RIPK1 (0.56) SLC1A2MMP8RIPK1RAB9A
SCHEMBL2578237 0.66 EPHX2 (0.62) EPHX2PPARARIPK1MMP2MMP3
SCHEMBL1695664 0.65 LOXL2 (0.57) EPHX2MAOAPPARAMMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 SLC1A3 2652/4885SLC1A2 2127/4885EPHX2 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.